ABVC BioPharma, Inc. (ABVC)
1.41
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma EPS Diluted (Quarterly) : -0.0613 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| Perspective Therapeutics, Inc. | -0.2528 |
| MiMedx Group, Inc. | -0.0732 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.690M |
| Total Expenses (Quarterly) | 1.560M |
| Enterprise Value | 41.25M |
| Earnings Yield | -27.61% |
| Normalized Earnings Yield | -26.03 |